Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals
Lipegfilgrastim (Lonquex) • Arznei-News
Frontiers | Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting | Oncology
LINKIX (Lipegfilgrastim) 6 MG SOL INY - Farmacia Edufer
LONQUEX leaflet 6mg x1 INJECTIBLE SOLUTION TEVA 1972.52 RON for phy...
Lipegfilgrastim | Teva UK
Filgrastim-Teva 48 Mio E/0.8ml 5 Fertspr 0.8 ml
Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges
Medicamentos
Lonquex 6 mg Injektionslosung in einer Fertigspritze